Joe Wilding, MD CPA
@JoeWildingMD
Followers
129
Following
819
Media
10
Statuses
157
Radiation oncologist at Virginia Commonwealth University
Richmond, VA
Joined July 2022
Grateful to the 500 rad oncs across all 50 states, DC, and Puerto Rico who contributed! 61% support for implementing an episode-based payment model. Broad support with >50% across all experience levels, hospital/freestanding, rural/suburban/urban, and U.S. regions
#CURiEAlert: "General Consensus on Implementing an Episode-Based Payment Model: Results From the @ACRORadOnc Payment Reform Survey" by Drs. Wilding, Clifford, Heron, Jahraus, Benitez, & Thomas is now published: https://t.co/euQlM3OqUF
2
4
15
Congratulations to our PGY4 Eliane Garlock (@ElianeGarlock) on being selected as the 2026 Government Relations Resident Fellow!
Congratulations to Eliane Garlock, DO, from the VCU Health System for being selected as ASTRO's 2026 Government Relations Resident Fellow! @ElianeGarlock
https://t.co/4NlVmaf6rh
0
1
4
📢 We're proud to announce our @ACRORadOnc Advocacy Fellows for 2025/26: Drs. Rojine Ariani and Kishan Patel! #ACROAdvocacy #ACROGREC
0
3
6
Fellow chief resident John Roubil (@JohnRoubil) had an oral presentation on his working with @StJude attending Dr. Lucas looking at patterns of failure after pencil beam scanning proton therapy in pediatric patients #ASTRO25
0
2
8
One poster stand over, chief resident Navid Fallahi (@NavidFallahi_MD) presented on his work also with attending Dr. Weiss looking at image registration and cumulative OAR doses for lung reirradiation cases #ASTRO25
1
2
5
#CURiEAlert: "Excess Cost of Telehealth Use in #RadOnc: A Medicare-Based Cohort Study" is published! This study analyzes Medicare beneficiaries who received external beam radiation therapy in outpatient hospital-based settings between 2020-2022: https://t.co/xTrO87xA76
0
3
7
Congratulations to our award winners! Community Advocate of the Year: Rev. Tyron Williams, D.Div., Pastor at Mount Olive Baptist Church Early Career Investigator of the Year: Can Senkal, PhD Clinicians of the Year: Keri Maher, DO and Alfredo Urdaneta, MD #LawrenceRetreat25
0
2
4
Looking forward to moderating this 🔥 webinar on role of #radiation ☢️ in treating #benign conditions including both #cns 🧠 and #msk 🦴 indications ft. @Tarita_ThomasMD and @SamuelChaoMD Join us as we explore these new indications of RT #osteoarthritis #gammaknife as a part of
0
5
27
We are so excited to have our new PGY2s join us this week! Thanks for joining the crew, Lauren, Amanda, and @aleckonradmed. Happy to have you on board!
3
3
15
Great meeting with Rep. John McGuire at @ASTRO_org #AdvocacyDay2025. We need your support for #ROCR!
0
2
12
0
2
7
Great meeting with Rep. Jennifer McClellan at @ASTRO_org #AdvocacyDay2025. We need your support for #ROCR!
0
2
8
We had a fantastic day at the ASTRO Advocacy Day discussing #ROCR, making prior auth more transparent, and research funding. Strong presence from Virginia! @ASTRO_org
0
3
9
We had a lovely meeting and thoughtful discussion about ROCR, prior auth reform, and cancer research funding with @timkaine's legislative fellow, Tracy Fasolino. Starting off ASTRO Advocacy Day strong. @ASTRO_org
0
2
17
My experience as an ACRO Advocacy Fellow was phenomenal and I encourage residents to apply for this special opportunity!
Become a 2025/26 ACRO Advocacy Fellow! This year-long program provides an avenue for residents to enhance understanding of #radiationoncology code development and valuation, payment reform, and state and federal health care policies. Learn more & apply: https://t.co/P2kgfRHreO
0
1
2
In our final installment of #MadMoneyMonday we celebrate Ethan Steele and Amanda Stark for their Seed Grant Awards. LAST CHANCE!! Deadline for 2025 Seed Grants is Today!!
0
2
12
It was an honor to recognize @ASTRO_org’s @PRJeffWhite with the #ACRO2025 Media Award for Patient Education. Jeff is an inspiration to us all. Thank you for your willingness to share your cancer journey and experiences. ☢️🩺
1
10
43
Excellent presentation @ACRORadOnc #ACRO2025 by @JohnRoubil on @IntRRF analysis on SRS for sarcoma brain metastases, showing favorable LC & OS. Leiomyosarcoma histologies and pts w/o progressive extracranial metastases had better OS
2
4
19